Search research articles
Contact Us
Filters
Showing results (291-300 of 305) with videos related to
Page
of 31
Sort By:
Science Advances
|
August 21, 2021
Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity
Wooi F Lim, Mitra Forouhan, Thomas C Roberts, et al.
ESMO Open
|
September 6, 2024
Capivasertib and fulvestrant for patients with hormone receptor-positive advanced breast cancer: characterization, time course, and management of frequent adverse events from the phase III CAPItello-291 study
H S Rugo, M Oliveira, S J Howell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2024
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)
A Fernandez-Martinez, M Tanioka, S G Ahn, et al.
Leukemia
|
March 25, 2017
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials
G Montalban-Bravo, X Huang, K Naqvi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2025
Overall survival with abemaciclib in early breast cancer
S Johnston, M Martin, J O'Shaughnessy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2021
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
A Bardia, S M Tolaney, K Punie, et al.
Leukemia
|
November 1, 2016
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials
G Montalban-Bravo, X Huang, K Naqvi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2026
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial
R Dent, Z Shao, P Schmid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
P Hadji, R E Coleman, C Wilson, et al.
The Journal of Infection
|
December 3, 2020
A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection
Veronica L Fowler, Bryony Armson, Jose L Gonzales, et al.
Page
of 31
Search research articles
Search
Showing results (291-300 of 305) with videos related to
Sort By:
Page
of 31
Science Advances
|
August 21, 2021
Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity
Wooi F Lim, Mitra Forouhan, Thomas C Roberts, et al.
ESMO Open
|
September 6, 2024
Capivasertib and fulvestrant for patients with hormone receptor-positive advanced breast cancer: characterization, time course, and management of frequent adverse events from the phase III CAPItello-291 study
H S Rugo, M Oliveira, S J Howell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2024
Prognostic value of residual disease (RD) biology and gene expression changes during the neoadjuvant treatment in patients with HER2-positive early breast cancer (EBC)
A Fernandez-Martinez, M Tanioka, S G Ahn, et al.
Leukemia
|
March 25, 2017
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials
G Montalban-Bravo, X Huang, K Naqvi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2025
Overall survival with abemaciclib in early breast cancer
S Johnston, M Martin, J O'Shaughnessy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 11, 2021
Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer
A Bardia, S M Tolaney, K Punie, et al.
Leukemia
|
November 1, 2016
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials
G Montalban-Bravo, X Huang, K Naqvi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 5, 2026
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial
R Dent, Z Shao, P Schmid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel
P Hadji, R E Coleman, C Wilson, et al.
The Journal of Infection
|
December 3, 2020
A highly effective reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assay for the rapid detection of SARS-CoV-2 infection
Veronica L Fowler, Bryony Armson, Jose L Gonzales, et al.
Page
of 31